Polyphenols and endogenous antioxidant defences: Effects on glutathione and glutathione-related enzymes;Polifenoli e difese antiossidanti endogene: Effetti sul glutatione e sugli enzimi ad esso correlati

Annali dell'Istituto Superiore di Sanita

Volumn 42, Issue 3, 2006, Pages 336-347

  Giovannini, Claudio ^a   Filesi, Carmela ^a   D'Archivio, Massimo ^a   Scazzocchio, Beatrice ^a   Santangelo, Carmela ^a   Masella, Roberta ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antioxidants; Glutathione; Polyphenols; Transcription factors

Indexed keywords

ANTIOXIDANT; GLUTATHIONE; POLYPHENOL DERIVATIVE;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; DEFENSE MECHANISM; DRUG MECHANISM; DRUG STRUCTURE; FRUIT; OXIDATIVE STRESS; PLANT; VEGETABLE;

ANIMALS; ANTIOXIDANTS; DIET; ENZYMES; FLAVONOIDS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; PHENOLS; PLANTS;

EID: 33845453816     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (151)

1. Davies KJ. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 1993;6:1-31.
2. Nohl H, Gille L, Staniek K. Intracellular generation of reactive oxygen species by mitochondria. Biochem Pharmacol 2005;69:719-23.
3. Szocs K. Endothelial dysfunction and reactive oxygen species production on ischemia/reperfusion and nitrate tolerance. Gen Physiol Biophys 2004;23:265-95.
4. Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, Tsuru K, Horikawa T. UV-induced skin damage. Tixicology 2003;189:21-39.
5. Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE. Free radicals and phagocitic cells FASEB J 1995;9:200-9.
6. Halliwell B and Gutteridge JMC. Free Radicals in Biology and Medicine. 3. ed. Oxford: Clarendon Press; 1999 (Chapter 4).
7. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004;266:37-56.
8. Halliwell B. Antioxidant defense mechanisms: from the beginning to the end. Free Rad Res 1999;31:261-72.
9. Gutteridge JMC. Free radicals in diseases processes: a compilation of cause and consequence. Free Rad Res Comm 1993;19:141-58.
10. Kehrer J. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993;23:21-48.
11. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005;10:1881-96.
12. Benzie IFF. Antioxidants: observational epidemiology. In: Sadler MJ, Strain JJ, Cabellero B (Ed.). The Encyclopedia of human nutrition. New York: Academic Press; 1999. p. 106-15.
13. Yao LH, Jiang YM; Shi J, Tomas-Barberan FA, Datta N, Singanusong R, Chen SS. Flavonoids in food and their health benefits. Plant Food Hum Nutr 2004;59:113-22.
14. Porrini M, Riso P, Brusamolino A, Berti C, Guarnieri S, Visioli F. Daily intake of a formulated tomato drink affects carotenoid plasma and lymphocyte concentrations and improves cellular antioxidant protection. Br J Nutr 2005;93:93-9.
15. Halliwell B. Antioxidants and human diseases: a general introduction. Nutr Rev 1997;55:S44-52.
16. Gawrieh S, Opana EC, Koch TR. Oxidative stress in non alcoholic fatty liver disease: pathogenesis and antioxidant therapies. J Invest Med 2004;52:506-14.
17. Gaetke LM, Chow CK. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 2003;189:147-63.
18. Rice-Evans C. Flavonoid antioxidants.Curr Med Chem 2001;8:797-807.
19. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Rad Biol Med 1996;20:933-56.
20. Rice-Evans C. Plant polyphenols: free radicals scavengers or chain-breaking antioxidants? Biochem Soc Symp 1995;61:103-16.
21. Hu JP, Calomme M, Lasure A, De Bruyne T, Pieters L, Vlietinck A, Van den Berge DA. Structure-activity relationship of flavonoids with superoxide scavenging activity. Biol Trace Elem Res 1995;47:327-31.
22. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leewen PA. Flavonoids: a review of probable mechanisms of action and potential applications Am J Clin Nutr 2001;74:418-25.
23. Manach C, Scalbert A, Morand C, Rémésy C, Jimenez L. Polyphenolis: food sources and bioavailability. Am J Clin Nutr 2004;79:727-47.
24. Huxley RR, Neil HAW. The relation between dietary flavonoid intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr 2003;57:904-8.
25. Hertog MGL, Hollman PCH. Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr 1996;50:63-71.
26. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005;81(Suppl. 1):317S-25S.
27. Sesso HD, Gaziano M, Buring JE, Hennekens CH. Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol 1999;149:162-7.
28. Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 1999;149:943-9.
29. Hertog MG, Bueno de Mesquita HB, Fehily AM, Sweetnam PM, Elwood PC, Kromhout D. Fruit and vegetable consumption and cancer mortality in the Caerphilly Study. Cancer Epidemiol Biomarkers Prev 1996;5:673-7.
30. Bors W, Michel C, Stettmaier K. Structure-activity relationships governing antioxidant capacities of plant polyphenols. Methods Enzymol 2001;335:166-80.
31. Spencer JPE, Srai SK, Rice-Evans C. Metabolism in the small intestine and gastrointestinal tract. In: Rice-Evans C, Parker L (Ed.). Flavonoids in health and disease. New York: Marcel Dekker; 2003. p. 363-90.
32. Heijnen CGM, Haenen GRMM, Oostveen RM, Stalpers EM, Bas A. Protection of flavonoids against lipid peroxidation: structure activity relationship revisited. Free Rad Res 2002;36:575-81.
33. Aviram M, Fuhrman B. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis. Atherosclerosis 1998;137:45-50.
34. Masella R, Cantafora A, Modesti D, Cardilli A, Gennaro L, Bocca A, Coni E. Antioxidant activity of 3,4-DHPEA-EA and protocatechuic acid: a comparative assessment with other olive oil biophenols. Redox Report 1999;4:113-21.
35. Coni E, Di Benedetto R, Di Pasquale M, Masella R, Modesti D, Mattel R, Carlini EA. Protective effect of oleuropein, an olive oil biophenol, on low density lipoprotein oxidizability in rabbits. Lipids 2000;35:45-54.
36. Masella R, Giovannini C, Varì R, Di Benedetto R, Coni E, Volpe R, Fraone N, Bucci A. Effects of dietary olive oil phenols on low density lipoprotein oxidation in hyperlipidemic patients. Lipids 2001;36:1195-202.
37. Szeto YT and Benzie IFF. Effects of dietary antioxidants on human DNA ex vivo. Free Rad Res 2002;36:113-8.
38. Elbling L, Weiss RM, Teufelhofer O, Uhl M, Knasmueller S, Schulte-Hermann R, Berger W, Micksche M. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J 2005;19(7):807-9.
39. Lambert JD, Hong J, Yang G, Liao J, Yang CS. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr. 2005; 81(Suppl): 284S-91S.
40. Luximon-Ramma A, Bahorun T, Soobratee M, Aruoma OI. Antioxidant activities of phenolic, proanthocyanidin and flavonoid components in extracts of Cassia fistula. J Agric Food Chem 2002;50:5042-7.
41. Azzi A, Davies KJA, Kelly F. Free radical biology: terminology and critical thinking. FEBS Lett 2004;558:3-6.
42. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Rad Biol Med 2000;28:463-99.
43. Torres M, Forman HJ. Redox signaling and the MAP kinase pathways. Biofactors 2003;17:287-96.
44. Kwon YW, Masutani H, Nakamura H, Ishii Y, Yodoi J. Redox regulation of cell growth and cell death. Biol Chem 2003;384:991-6.
45. Donovan JL, Waterhouse AL. Bioavailability of flavanol monomers. In: Rice-Evans C, Parker L (Ed.). Flavonoids in health and disease. New York: Marcel Dekker; 2003. p. 413-40.
46. Spencer JPE, Abd El Mohsen MM, Rice-Evans C. Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys 2004;423:148-61.
47. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005;81(Suppl):230S-42S.
48. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II: Review of 93 intervention studies. Am J Clin Nutr 2005;81(Suppl.):243S-55S.
49. Naasani I, Oh-Hashi F, Oh-Hara T et al. Blocking telomerase by dietary polyphenols is a major mechanisms for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res 2003;63:824-30.
50. Laughton MJ, Evans PJ, Moroney MA, Hoult JRS, Halliwell B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives: relationship to antioxidant activity and to iron ion-reducing ability. Biochem Pharmacol 1991;42:1673-81.
51. O'Leary KA, de Pascual-Tereasa S, Needs PW, Bao YP, O'Brien NM, Williamson G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2). Mutat Res 2004;551:245-54.
52. Hussain T, Gupta S, Adhami VM, Mukhtar H. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer 2005;113:660-9.
53. Schewe T, Sadik C, Klotz L-O, Yoshimoto T, Kuhn H, Sies H. Polyphenols of cocoa: inhibition of mammalian 15-lipoxygenase. Biol Chem 2001;382:1687-96.
54. Sadik CD, Sies H, Schewe T. Inhibition of 15-lipoxygenase by flavonoids: structure-activity relations and mode of action. Biochem Pharmacol 2003;65:773-81.
55. Van Hoorn DEC, Nijveldt RJ, Van Leeuwen PAM, Hofman Z, M'Rabet L, De Bont DB, Van Norren K. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Pharmacol 2002;451:111-8.
56. Isemura M, Saeki K, Minami T et al. Inhibition of matrix metalloproteinases by tea catechins and related polyphenols. Ann NY Acad Sci 1999;878:629-31.
57. Oak MH, El Bedoui J, Anglard P, Schini-Kerth VB. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells. Circulation 2004;110:1861-7.
58. Actis-Goretta L, Ottaviani JI, Keen CL, Fraga CG. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett 2003;555:597-600.
59. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, Chap H, Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997;53:1649-57.
60. Gamet-Payrastre L, Manenti S, Gratacap MP, Tulliez J, Chap H, Peyrastre B. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 1999;32:279-86.
61. Wiseman S, Mulder T, Rietveld A. Tea flavonoids: bioavailability in vivo and effects on cell signaling pathway in vitro. Antiox Redox Signal 2001;3:1009-21.
62. Kong An, Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res 2000;23:1-16.
63. Spencer JP, Rice-Evans C, Williams RJ. Modulation of pro-survival Akt/PKB and ERK1/2 signalling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 2003;278:34783-93.
64. Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E, Bohm M. Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the "French Paradox". FASEB J 2002;16:1958-60.
65. Mueller So, Simon S, Chae K, Metzler M, Korach KS. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 2004;80:14-25.
66. Way TD, Kao MC, Lin JK. Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells. FEBS Lett 2005;579:145-52.
67. Monasterio A, Urdaci MC, Pinchuk IV, Lopez-Moratalla N, Martinez-Irujo JJ. Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways. Nutr Cancer 2004;50:90-100.
68. Sergeev IN. Genistein induces Ca2+-mediated, calpain/caspase-12-dependent apoptosis in breast cancer cells. Biochem Biophys Res Comm 2004;321:462-7.
69. Fischer PM, Lane DP. Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics. Curr Med Chem 2000;7:1213-45.
70. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 2001;90:157-77.
71. Aldini G, Carini M, Piccoli A, Rossoni G, Facino RM. Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidence for cardio-protection. Life Science 2003;73:2883-98.
72. Wallerath T, Poleo D, Li H, Fostermann U. Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects. J Am Coll Cardiol 2003;41:471-8.
73. Murphy KJ, Chronopoulos AK, Singh I, Francis MA, Moriarty H, Pike MJ, Turner AH, Mann NJ, Sinclair AJ. Dietary flavanols and procyanidin oligomers from cocoa (Teobroma cacao) inhibit platelet function. Am J Clin Nutr 2003;77:1466-73.
74. Vera JC, Reyes AM, Càrcamo JG, Velasquez FV, Rivas CI, Zhang RH, Strobel P, Iribarren R, Scher HI, Siebe JC et al. Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter GLUT1. J Biol Chem 1996;271:8719-24.
75. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defense against oxidative stress. Free Rad Biol Med 1999;31:273-300.
76. Talalay P. Chemoprotection against cancer by induction of phase II enzymes. Biofactors 2000;12:5-11.
77. Arnér ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 2000;267:6102-9.
78. Matés J, Pérez-Gomez C, Nùnez De Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999;32:595-603.
79. Chaudière J, Ferrari-Iliou R. Intracellular Antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol 1999;37:949-62.
80. Armstrong RN. Structure, catalytic mechanism and evolution of the glutathione transferase. Chem Res Toxicol 1997;10:2-18.
81. Brigelius-Flohè R. Tissue-specific functions of individual glutathione peroxidases. Free Rad Biol Med 1999;27:951-65.
82. Kuhn H, Borchert A. Regulation of enzymatic lipid peroxidation: the interplay of peroxidizing and peroxide reducing enzymes. Free Rad Biol Med 2002;33:154-72.
83. Akerboom TPM, Sies H. Transport of glutathione, glutathione disulfide, and glutathione conjugates across the hepatocyte plasma membrane. Methods Enzymol 1989;134:523-34.
84. Sies H. Glutathione and its role in cellular functions. Free Rad Biol Med 1999;27:916-21.
85. Meister A, Anderson ME. Glutathione. Ann Rev Biochem 1983;52:711-60.
86. Kalyanaraman B, Karoui H, Singh RJ, Felix CC. Detection of thiyl radical adducts formed during hydroxyl radical- and peroxynitrite-mediated oxidation of thiols- a high resolution ESR spin-trapping study at Q-band. Anal Biochem 1996;241:75-81.
87. Briviba K, Klotz LO, Sies H. Defenses against peroxynitrite. Methods Enzymol 1999;301: 301-11.
88. Pompella A, Visvikis A, Paolicchi A, de Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003;66:1499-503.
89. Ursini F, Maiorino M, Brigelius-Flohé R, Aumann KD, Roveri A, Schomburg D, Flohé L. The diversity of glutathione peroxidases. Methods Enzymol 1995;252 B:38-53.
90. Nakashima I, Takeda K, Kawamoto Y, Okuno Y, Kato M, Suzuki H Redox control of catalytic activities of membrane-associated protein tyrosine kinases. Arch Biochem Biophys 2005;434:3-10.
91. Hayes JD Flanagan JU, Jowsey IR. Glutathione Transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
92. Argyrou A, Blanchard JS. Flavoprotein disulfide reductases: advances in chemistry and function. Prog Nucleic Acid Res Mol Biol 2004;78:89-142.
93. Rogers LK, Tamura T, Rogers BJ, Welty SE, Hansen TN, Smith CV. Analyses of glutathione reductase hypomorphic mice indicate a genetic knockout. Toxicol Sci 2004;82:367-73.
94. Lu SC. Regulation of glutathione synthesis. Curr Top Cell Regul 2000;36:95-116.
95. Steele VE, Kelloff GJ, Balentine D, Boone CW, Metha R, Bagheri D, Sigman CC, Zhu S, Sharma S. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis 2000;21:63-7.
96. Scharf G, Prustomersky S, Knasmuller S, Schulte-Hermann R, Huber WW. Enhancement of glutathione and γ-glutamyl-cysteine synthetase, the rate limiting enzyme of glutathione synthesis, by chemoprotective plant-derived food and beverage components in the human hepatoma cell line HepG2. Nutr Cancer 2003;45:74-83.
97. Ramirez-Mares MV, Gonzales de Mejia E. Comparative study of the antioxidant effect of ardisin and epigallocatechin gallate in rat hepatocytes exposed to benomyl and 1-nitropyrene. Food Chem Toxicol 2003;41:1527-35.
98. Jeon SE, Choi-Kwon S, Park KA, Lee HJ, Park MS, Lee JH, Kwon SB, Park KC. Dietary supplementation of (+)-catechin protects against UVB-induced skin damage by modulating antioxidant enzyme activities. Photodermatol Photoimmunol Photomed 2003;19:235-41.
99. Soto C, Recoba, R, Barrón H, Alvarez C, Favari, L. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp Biochem Physiol C Toxicol Pharmacol 2003;136:205-12.
100. Molina MF, Sanchez-Reus I, Iglesias I, Benedi J. Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol Pharma Bull 2003; 26:1398-1402.
101. Cao Z, Li Y. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur J Pharmacol 2004; 489:39-48.
102. Chen L, Yang XQ, Jiao H, Zhao B. Effect of tea catechins on the change of glutathione levels caused by Pb++ in PC12 cells. Chem Res Toxicol 2004;17:922-8.
103. Rodrigo R, Rivera G, Orellana M, Araya J, Bosco C. Rat kidney antioxidant response to long-term exposure to flavonol rich red wine. Life Science 2002;71:2881-95.
104. Rodrigo R, Castillo R, Carrasco R, Huerta P, Moreno M. Diminution of tissue lipid peroxidation in rats is related to the in vitro antioxidant capacity of wine. Life Science 2005; 76:889-900.
105. Khan N, Sultana S. Abrogation of potassium bromate-induced renal oxidative stress and subsequent cell proliferation response by soy isoflavones in Wistar rats. Toxicology 2004; 201:173-84.
106. Fitó M, Cladellas M, de la Torre R, Martí J, Alcántara M, Pujadas-Bastardes M, Marrugat J, Bruguera J, López-Sabater MC, Vila J, Covas MI. Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atheroslerosis 2005;181:149-158.
107. Masella R, Varì R, D'Archivio M, Di Benedetto R, Matarrese P, Malorni W, Scazzocchio B, Giovannini C. Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes. J Nutr 2004;134:785-91.
108. Gohil K, Mory RK, Farzin S, Maguire JJ, Packer L. mRNA expression profile of a human cancer cell line in response to Ginkgo biloba extract: induction of antioxidant response and the Golgi system. Free Rad Res 2000;33:831-49.
109. Waever CM, Liebman M. Biomarkers of bone health appropriate for evaluating functional foods designed to reduce risk of osteoporosis. Br J Nutr 2002;88(Suppl.2):S225-32.
110. Vayalil PK, Elmets CA, Katiyar SK. Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 2003;24:927-36.
111. Luceri C, Caderni G, Sanna A, Dolora P. Red Wine and Black Tea Polyphenols Modulate the Expression of Cycloxygenase-2, Inducible Nitric Oxide Synthase and Glutathione-Related Enzymes in Azoxymethane-Induced F344 Rat Colon Tumors. J Nutr 2002;132:1376-79.
112. Suzuki K, Koike H, Matsui H, Ono Y, Hasumi M, Nakazato H, Okugi H, Sekine Y, Oki K, Ito K, Yamamoto T, Fukabori Y, Kurokawa K, Yamanaka H. Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCAP and PC-3. Inter J Cancer 2002;99:846-52.
113. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Malone WA, Boone CW, Kopelovich L, Hawk ET, Lieberman R, Lawrence JA, Ali I, Viner JL, Sigman CC. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 2000;130 (Suppl. 2S):467S-71.
114. Fiander H, Schneider H. Dietary orto-phenols that induce glutathione S-transferase and increase the resistance of cells to hydrogen peroxide are potential cancer chemopreventives that act by two mechanisms: the alleviation of oxidative stress and the detoxification of mutagenic xenobiotics. Cancer Lett 2000;156:117-24.
115. Kuntz S, Wenzel U, Daniel H. Comparative analysis of the effects of flavonoids on proliferation. Cytotoxicity and apoptosis in human colon cancer cell lines. Eur J Nutr 1999; 38:133-42.
116. Van Zanden JJ, Geraets L, Worteboer HM, Van Bladeren PJ, Rietjens IMCM, Cnubben NHP. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase and GS-X pump activity in MCF7 breast cancer cells. Biochem Pharmacol 2004;67:1607-17.
117. Depeint F, Gee JM, Williamson G, Johnson IT. Evidence for consistent patterns between flavonoid structures and cellular activities. Proc Nutr Soc 2002;61:97-103.
118. Fukao T, Hosono T, Misawa S, Seki T, Ariga T. The effects of allyl sulfides on the induction of phase II detoxification enzymes and liver injury by carbon tetrachloride. Food Chem Toxicol 2004;42:743-9.
119. Dhakshinamoorthy S, Long DJ II, Jaiswal AK. Antioxidant regulation of genes encoding enzymes that detoxify xenobiotica and carcinogens. Curr Top Cell Regul 2000;36:201-6.
120. Jaiswal AK. Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Rad Biol Med 2000;29:254-62.
121. Wasserman WW, Fahl WE. Functional antioxidant responsive elements. Proc Natl Acad Sci 1997;94:5361-6.
122. Nguyen T, Sherratt PJ, Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol 2003;43:233-60.
123. Lee JM, Johnson JA. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 2004;37:139-43.
124. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the ammo-terminal Neh2 domain. Genes Dev 1999;13:76-86.
125. Itoh K, Wakabashi N, Katoh Y, Ishii T, O'connor T, Yamamoto M. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 2003;8:379-91.
126. Nguyen T, Yang CS, Pickett CB. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Rad Biol Med 2004;37:433-41.
127. Dinkova-Kostova AT, Holzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P. Direct evidence that sulphydryl groups of Keap1 are the sensors regulating induction of phase II enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci 2002;99:11908-13.
128. Venugopal R, Jaiswal AK. Nfr2 and Nrf1 in association with cJun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 1998;17:3145-56.
129. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophysic Res Comm 1997;236:313-22.
130. Dhakshinamoorthy S, Jaiswal AK. c-Maf negatively regulates ARE-mediated detoxifying enzyme gene expression and antioxidant induction. Oncogene 2002;21:5301-12.
131. Wasserman WW, Fahl WE. Comprehensive analysis of proteins which interact with the antioxidant responsive element: correlation of ARE-BP-1 with the chemopreventive induction response. Arch Biochem Biophys 1997;344:387-96.
132. Huang HC, Nguyen T, Pickett CB. Phosphorilation of Nrf2 at ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 2002;277:42769-74.
133. Kang KW, Choi SH, Kim SG. Peroxynitrite activates NF-E2-related factor 2/antioxidant response element through the pathway of phosphatidylinositol 3-kinase: The role of nitric oxide synthase in rat glutathione S-transferase A2 induction. Nitric Oxide 2002;7:244-53.
134. Nakaso K, Yano H, Fukuhara Y, Takeshima T, Wada-Isoe K, Nakashima K. PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett 2003;546:181-4.
135. Zipper LM, Mulcahy RT. Inhibition of ERK and p38 MAPkinases inhibits binding of Nrf2 and induction of GCS genes. Biochem. Biophys Res Comm 2000;278:484-92.
136. Myhrstad MCW, Carlsen H, Nordstrom O, Blomhoff R, Moskaug JO. Flavonoids increases the intracellular glutathione level by transactivation of the γ-glutamylcysteine synthetase catalytic subunit promoter. Free Rad Biol Med 2002;32:386-93.
137. Moskaug JO, Carlsen H, Myhrstad MCW, Blumhoff R. Polyphenols and glutathione synthesis regulation. Am J Clin Nutr 2005;81(Suppl.):277S-83S.
138. Valerio LG Jr, Kepa JK, Pickwell GV, Quattrocchi LC. Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin. Toxicol Lett 2001;119:49-57.
139. Toyokuni S, Tanaka T, Kawaguchi W, Fang NR, Ozeki M, Akatsuka S, Hiai H, Aruoma OI, Bahorun T. Effects of the phenolic contents of Mauritian endemic plant extracts on promoter activities of antioxidants enzymes. Free Rad Res 2003;37:1215-24.
140. Myhrstad MCW, Dinkova-Kostova AT, Talalay P. Relation of structure of curcumin analogs to their potencies as inducers of phase 2 detoxyfication enzymes. Carcinogenesis 1999;20:911-4.
141. Chen C, Yu R, Owuor ED, Kong AN. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenols components during cell survival and death. Arch Pharm Res 2000;23:605-12.
142. Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, Talalay P. Potency of the Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA 2001;98:3404-9.
143. Galati G, Moridiani MY, Chan TS, O'Brien PJ. Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation. Free Rad Biol Med 2001;30:370-82.
144. Levonen Al, Landar A, Ramachandran A, Caeser EK, Dickinson DA, Zanoni G, Morrow JD, Darley-Usmar VM. Cellular mechanisms of redox cell signaling: role of cysteine modification in controlling antioxidant defenses in response to electrophilic lipid oxidation products. Biochem J 2004;378:373-82.
145. Yu R, Tan TH, Kong A-NT. Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants. J Biol Chem 1997; 272:28962-70.
146. Yu R, Jiao JJ, Duh JL, Gudehithlu K, Tan TH, Kong AN. Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis 1997;18:451-6.
147. Kong AN, Owuor E, Yu R, Hebbar V, Chen C, Hu R, Mandlekar S. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab Rev 2001;33:255-71.
148. Lang M, Cai L, Udeani GO, Slowing KV, Thomas CF , Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-20.
149. Niles RM, McFarland M, Weimer MB, Redkar A, Fu YM, Meadows GG. Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett 2003;190:157-63.
150. She QB, Huang C, Zhang Y, Dong Z. Involvement of c-jun NH2 terminal kinases in resveratrol-induced activation of p53 and apoptosis. Mol Carcinog 2002;33:244-50.
151. Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer 2004;109:167-73.